Description

BIM 23056, a linear octapeptide, is a potent sst3 and sst5 somatostatin receptor antagonist with Ki values of 10.8, 5.7, respectively[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Neuroscience-Neuromodulation–C71H81N11O9—-[1]Y C Patel, et al. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 1994 Dec;135(6):2814-7.|[2]W Feniuk, et al. Further evidence from functional studies for somatostatin receptor heterogeneity in guinea-pig isolated ileum, vas deferens and right atrium. Br J Pharmacol. 1995 Jul;115(6):975-80.–150155-61-6–1232.47–99.94–OC(C=C1)=CC=C1C[C@H](NC([C@@H](NC([C@H](N)CC2=CC=CC=C2)=O)CC3=CC=CC=C3)=O)C(N[C@@H](C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](C(N)=O)CC4=CC5=C(C=CC=C5)C=C4)=O)CC6=CC=CC=C6)=O)=O)=O)CC7=CNC8=CC=CC=C78)=O–Neurological Disease–DMSO : 100 mg/mL (ultrasonic)–Somatostatin Receptor–SSTR3;SSTR5–GPCR/G Protein;Neuronal Signaling–Peptides